28 reports

A recent market study published on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the historical and current growth parameters of the Human Growth Hormone Treatment...

  • Human Growth Hormone
  • World
  • Latin America
  • North America
  • Western Europe
  • Eastern Europe
  • Japan

Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...

  • Human Growth Hormone
  • World
  • Drug Approval
  • Disposable Income

Human Growth Hormone (HGH) market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Human Growth Hormone (HGH) Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Human Growth Hormone (HGH) types, applications....

  • Human Growth Hormone
  • World

Human Growth Hormone (HGH) Market Report Overview Human Growth Hormone (HGH) market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Human Growth Hormone (HGH) market types and applications. It is a focused study on Human Growth Hormone (HGH)...

  • Human Growth Hormone
  • World
  • Health Provider Density

Global Human Growth Hormone Market 2022-2026 The analyst has been monitoring the human growth hormone market and it is poised to grow by $ 1.16 bn during 2022-2026 progressing at a CAGR of 5.44% during the forecast period. Our report on the human growth hormone market provides a holistic analysis, market size and forecast,...

  • Human Growth Hormone
  • World
  • Drug Approval

The global human growth hormone market reached a value of US$ 4.8 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 7.9 Billion by 2027, exhibiting a CAGR of 8.47% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • Human Growth Hormone
  • World

The Global Human Growth Hormone Market size is expected to reach $7.1 billion by 2025, rising at a market growth of 8.3% CAGR during the forecast period. Human growth hormone (HGH), also referred to as somatotropin, is a peptide hormone that stimulates growth, helps in cell reproduction as well as regeneration in humans. It is therefore important...

  • Human Growth Hormone
  • World
  • Spain
  • Asia
  • Europe
  • APAC

Human Growth Hormone Market Size, Share & Trends Analysis Report By Application (Growth Hormone Deficiency, Turner Syndrome), By Distribution Channel, By Region, And Segment Forecasts, 2020 - 2027 The global human growth hormone market size is expected to reach a value of USD 8.5 billion by 2027, registering a CAGR...

  • Human Growth Hormone
  • World
  • APAC
  • Denmark
  • North America
  • South Korea
  • Switzerland

Major players in the biosimilar growth hormone market are Biopartners And LG Chem, Amega Biotech, Eli Lilly and Company, Genetech Inc., Novartis AG, Zhongshan Hygene Biopharm Co. Ltd., Merck, Sanofi S.A., Biosidus, and Ferring Pharmaceuticals. The global biosimilar growth hormones market is expected to grow from $0.52 billion in 2020...

  • Human Growth Hormone
  • World
  • APAC

Human Growth Hormone (hGH) Market by Application (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Small for Gestational Age, and Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Oral), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, and Online Pharmacy): Global...

  • Pharmacy
  • Human Growth Hormone
  • In-Store Retail
  • E-Commerce
  • World
  • APAC
  • Europe
  • Chronic Disease Prevalence
  • Health Expenditure

Major players in the biosimilar growth hormone market are Biopartners And LG Chem, Amega Biotech, Eli Lilly and Company, Genetech Inc., Novartis AG, Zhongshan Hygene Biopharm Co. Ltd., Merck, Sanofi S.A., Biosidus and Ferring Pharmaceuticals. The global biosimilar growth hormones market is expected to grow from $0.59 billion in 2021...

  • Human Growth Hormone
  • World
  • United States
  • Middle East
  • APAC

The global drug screening market reached a value of US$ 5.42 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 9.36 Billion by 2027, exhibiting a CAGR of 9.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...

  • Analgesic
  • Public Health
  • Human Growth Hormone
  • Opioid
  • Road Safety
  • Patient Data Management
  • Occupational Health
  • Sports League
  • World

Drugs For Hormonal Replacement Therapy Global Market Report 2020-30: Covid 19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global drugs for hormonal replacement therapy market as it emerges from the Covid 19 shut down. Description: Where...

  • Human Growth Hormone
  • Marketing Research
  • In-Store Retail
  • Pharmacy
  • Infectious Disease
  • Endocrine Disease
  • Hormone
  • World

The Asia Pacific Human Growth Hormone Market would witness market growth of 9.7% CAGR during the forecast period (2019-2025). The growth hormone helps in increasing height during childhood, raises calcium retention levels, strengthens and improves bone mineralization. It also increases the muscle mass through sarcomere hypertrophy,...

  • Human Growth Hormone
  • Pharmacy
  • In-Store Retail
  • Asia
  • APAC

The Europe Human Growth Hormone Market would witness market growth of 7.9% CAGR during the forecast period (2019-2025). In addition, initiatives taken by various government and private organizations to raise awareness of GH deficiencies and human growth hormone therapy are expected to drive the market. Every year, the International...

  • Human Growth Hormone
  • Europe

The Latin America, Middle East and Africa Human Growth Hormone Market would witness market growth of 9.4% CAGR during the forecast period (2019-2025). Excessive release of growth hormones induces pituitary tumor, consisting of the anterior pituitary somatotroph cells. Such somatotroph cells are healthy and grow slowly, releasing excess...

  • Human Growth Hormone
  • Pharmacy
  • In-Store Retail
  • Middle East
  • Latin America
  • Argentina
  • Saudi Arabia
  • South Africa
  • Africa
  • Brazil
  • United Arab Emirates

The North America Human Growth Hormone Market would witness market growth of 7.7% CAGR during the forecast period (2019-2025). Growth hormone (GH) is a substance in the body that helps children grow and mature. It is made by a pituitary gland, which is a small gland between the lobes of the brain. Growth Hormone Deficiency (GHD) is...

  • Human Growth Hormone
  • Pharmacy
  • North America

“Somatropin– Biosimilar 2022,” report provides comprehensive insights about 10+ companies and 10+ marketed and pipeline drugs in Somatropin Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of...

  • Human Growth Hormone
  • World

This study covers the world outlook for human growth hormone (HGH) drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Human Growth Hormone
  • World
  • Gross Domestic Product
  • Disposable Income

ASEAN and China Biosimilars Market by Molecule Type (Human Growth Hormone, Erythropoietin, Monoclonal Antibody, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, and Peptide), and Application (Blood Disorder, Oncology Disease, Chronic & Autoimmune Disease, Growth Hormone Deficiency, and Others): Opportunity Analysis and Industry...

  • Biopharmaceutical
  • Autoimmune Disease
  • Human Growth Hormone
  • Blood Disease
  • Colony Stimulating Factor
  • Monoclonal Antibody
  • Arthritis
  • China
  • ASEAN

Human Growth Hormone (hGH) is a peptide hormone produced by the pituitary gland that stimulates growth in children and adults. It plays an important role in the functioning of the human body by regulating body fluids, muscle and bone growth and fat metabolism of the body. The deficiency of growth hormone in the body...

  • Human Growth Hormone
  • World
  • United States
  • Health Expenditure
  • Cancer Incidence

This study covers the world outlook for biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

  • Biopharmaceutical
  • Protein Therapy
  • Spacecraft
  • Satellite Launch
  • Human Growth Hormone
  • Blood Disease
  • Colony Stimulating Factor
  • Autoimmune Disease
  • Packaging
  • Infectious Disease
  • Mouth Disease
  • Monoclonal Antibody
  • Beef
  • World
  • Gross Domestic Product
  • Disposable Income

Scope of the Report The report titled “Global Growth Hormone (GH) Market: Size, Trends & Forecasts (2018-2022)” provides analysis of the global growth hormone market, with detailed analysis of growth hormone market in terms of its value and its subsequent segments. The report also includes a brief analysis of the...

  • Human Growth Hormone
  • World
  • Health Expenditure
  • HIV Incidence

Executive Summary The report presents the market potential of four major pipeline drugs (TransCon-hGH, Somapacitan, Somavaratan, Somatrogonmeant) for the treatment of human Growth Hormone Deficiency (GHD). These four drugs that fall in the various categories of paediatrics and adults by end user have been recognized as...

  • Human Growth Hormone
  • World
  • Health Expenditure
  • Young Population

This report analyzes the worldwide markets for Human Growth Hormone Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided...

  • Human Growth Hormone
  • World
  • APAC

OpportunityAnalyzer: Growth Hormone Deficiency - Opportunity Analysis and Forecasts to 2026 Summary Growth hormone deficiency (GHD) is a rare endocrine disorder characterized by inadequate secretion of growth hormone (GH), also called Somatropin, from the anterior pituitary gland located at the base of the brain (NORD,...

  • Human Growth Hormone
  • United States
  • World
  • Drug Approval
  • Biosimilar Penetration Rate

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics,...

  • Biosimilar
  • Monoclonal Antibody
  • Human Growth Hormone
  • World
  • Biosimilar Penetration Rate
  • Biosimilar Approvals

About Human Growth Hormone Human growth hormone, also known as somatotropin, is a peptide with 191 amino acids and 2 sulfhydryl bridges. It is produced by the anterior pituitary, and it is required to attain normal size for children and adolescents. It also has major effects on lipid and carbohydrate metabolism of an individual. The effects...

  • Human Growth Hormone
  • United States
  • World
  • Drug Approval
  • Prescription Drug Sales